Accuray Inc
ARAYNasdaqCIK 1138723HealthcareFiscal year ends Jun 30
Reports and events: 363 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-1616:33 ET | DEF 14A | Proxy statementPeriod 2026-11-19 | 0001140361-26-039918 |
| 2026-10-1316:03 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001437749-26-032558 |
| 2026-10-0616:02 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-032174 |
| 2026-09-0220:00 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-26-104846 |
| 2026-08-2716:02 ET | 10-K | Annual reportPeriod 2026-06-30 | 0001437749-26-029098 |
| 2026-08-2416:02 ET | DEF 14A | Proxy statementPeriod 2026-10-06 | 0001140361-26-034187 |
| 2026-08-1916:04 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-028532 |
| 2026-08-0616:01 ET | 8-K | 3.01 Delisting notice | 0001437749-26-026250 |
| 2026-07-2917:25 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-024904 |
| 2026-06-0416:02 ET | 8-K | 1.02 Termination of a material agreement; 7.01 Regulation FD disclosure | 0001437749-26-019558 |
| 2026-05-2215:57 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-26-065674 |
| 2026-05-0616:09 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001437749-26-015199 |
| 2026-05-0616:07 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-015198 |
| 2026-04-2809:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001437749-26-013543 |
| 2026-04-1706:03 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-26-044547 |
| 2026-04-0709:00 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001437749-26-011547 |
| 2026-04-0609:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-011313 |
| 2026-03-1916:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001437749-26-009046 |
| 2026-02-1706:20 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-004223 |
| 2026-02-1706:20 ET | 10-Q | Quarterly reportPeriod 2025-12-31 | 0001437749-26-004221 |
| 2026-02-1706:18 ET | 10-Q/A | Quarterly report, amendedPeriod 2025-09-30 | 0001437749-26-004220 |
| 2026-02-1706:17 ET | 10-K/A | Annual report, amendedPeriod 2025-06-30 | 0001437749-26-004219 |
| 2026-02-0916:08 ET | 8-K | 4.02 Non-reliance on financial statements | 0001437749-26-003515 |
| 2026-02-0616:05 ET | 8-K | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001437749-26-003367 |
| 2026-02-0416:05 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-002976 |
| 2026-01-2017:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-016769 |
| 2025-12-3116:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001437749-25-039074 |
| 2025-12-1606:02 ET | 8-K | 1.01 Entry into a material agreement; 2.05 Exit or disposal costs; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-319896 |
| 2025-11-1916:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-25-288077 |
| 2025-11-0516:16 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-266985 |
| 2025-11-0516:11 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-266940 |
| 2025-10-2009:20 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-25-243143 |
| 2025-10-0116:02 ET | DEF 14A | Proxy statementPeriod 2025-11-13 | 0001140361-25-036983 |
| 2025-09-1916:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-25-209044 |
| 2025-08-2816:15 ET | 10-K | Annual reportPeriod 2025-06-30 | 0001193125-25-191242 |
| 2025-08-2216:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-25-186407 |
| 2025-08-1316:05 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-179806 |
| 2025-06-1713:25 ET | SCHEDULE 13D | Ownership report, active investor | 0001104659-25-060187 |
| 2025-06-0607:36 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950103-25-007090 |
| 2025-05-0216:05 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-062744 |
| 2025-04-3016:10 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-061055 |
| 2025-02-0716:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-25-016249 |
| 2025-02-0516:15 ET | 10-Q | Quarterly reportPeriod 2024-12-31 | 0000950170-25-014485 |
| 2025-02-0516:03 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-014445 |
| 2025-01-2109:20 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-007015 |
| 2024-12-1116:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-24-275526 |
| 2024-11-2516:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-24-130548 |
| 2024-11-0616:20 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-122358 |
| 2024-11-0616:10 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-122304 |
| 2024-10-2116:10 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-115941 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 16:06 ET. Listed shows no prices and gives no investment advice.